Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Non-Current Assets (2016 - 2025)

Prestige Consumer Healthcare has reported Non-Current Assets over the past 15 years, most recently at $3.1 billion for Q4 2025.

  • For Q4 2025, Non-Current Assets rose 3.69% year-over-year to $3.1 billion; the TTM value through Dec 2025 reached $11.9 billion, up 1.19%, while the annual FY2025 figure was $3.0 billion, 0.36% changed from the prior year.
  • Non-Current Assets for Q4 2025 was $3.1 billion at Prestige Consumer Healthcare, up from $2.9 billion in the prior quarter.
  • Over five years, Non-Current Assets peaked at $3.4 billion in Q4 2021 and troughed at $2.9 billion in Q3 2024.
  • A 5-year average of $3.1 billion and a median of $3.0 billion in 2023 define the central range for Non-Current Assets.
  • Biggest five-year swings in Non-Current Assets: grew 6.9% in 2022 and later fell 12.3% in 2023.
  • Year by year, Non-Current Assets stood at $3.4 billion in 2021, then fell by 1.28% to $3.3 billion in 2022, then fell by 11.82% to $2.9 billion in 2023, then grew by 0.22% to $3.0 billion in 2024, then grew by 3.69% to $3.1 billion in 2025.
  • Business Quant data shows Non-Current Assets for PBH at $3.1 billion in Q4 2025, $2.9 billion in Q3 2025, and $3.0 billion in Q2 2025.